Company attributes
Location
Pitchbook URL
Founded Date
2016
Other attributes
Company Operating Status
Active
ALS Investment Fund is a venture capital firm in Amsterdam that focuses on supporting and finances biotech companies. Founded 2016 in Amsterdam, Noord-Holland, The Netherlands, it invests in series A, series C and venture rounds. Its portfolio companies include Apic Bio, Verge Genomics, Emulate, Orphazyme, and Amylyx Pharmaceutical. As of March 2020, ALS Investment Fund has made five investments. Their most recent investment was on January 7, 2019, when Apic Bio raised $40M. ALS Investment Fund has had one exit, which was Orphazyme. Apic Bio, Inc. is a biotechnology company that advances therapies to treat rare diseases with complex mechanisms.
Timeline
No Timeline data yet.
Funding Rounds
Products
Acquisitions
SBIR/STTR Awards
Invested in
Associated Investment Funds
Accelerator Batches
Patents
Funding Rounds Participated In
Further Resources
No Further Resources data yet.